Status:
UNKNOWN
Pulmonary Function Tests Study in Cirrhotic Patients With and Without Hepatocellular Carcinoma
Lead Sponsor:
Sohag University
Conditions:
Pulmonary Complications of Liver Cirrhosis and HCC
Eligibility:
All Genders
18-95 years
Brief Summary
Cirrhosis is a terminal image of chronic liver disease. During the progression from the compensation period to the decompensation period, various complications occur, and the life prognosis is signifi...
Detailed Description
Cirrhosis is a terminal image of chronic liver disease. During the progression from the compensation period to the decompensation period, various complications occur, and the life prognosis is signifi...
Eligibility Criteria
Inclusion
- Adult patients diagnosed with liver cirrhosis with and without HCC depending on clinical evidence of stigmata of liver disease (e.g. jaundice, ascites, palmar erythema, spider navi, etc), laboratory data and ultra-sonographic features.
Exclusion
- Patients with primary pulmonary pathology.
- Coexisting intrinsic heart disease.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05963776
Start Date
September 1 2023
End Date
September 1 2024
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University hospitals
Sohag, Egypt